Advertisement
Physiology in Medicine| Volume 104, ISSUE 3, P301-309, March 1998

Liddle’s Syndrome

  • Biff F Palmer MD
    Correspondence
    Biff F. Palmer, MD, Associate Professor of Internal Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75235.
    Affiliations
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
    Search for articles by this author
  • Robert J Alpern MD
    Affiliations
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
    Search for articles by this author
  • In collaboration with The American Physiological Society, Thomas E. Andreoli, MD, Editor
      Liddle’s syndrome is characterized by hypertension in the setting of hypokalemic metabolic alkalosis. Clinically these patients resemble those with primary hyperaldosteronism. However, the hallmark of this disorder is the finding of markedly suppressed serum aldosterone levels and the lack of response to administration of the mineralocorticoid receptor blocker spironolactone. In the original classic report of this disorder in 1963, Liddle et al [
      • Liddle GW
      • Bledsoe T
      • Coppage Jr, WS
      A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion.
      ]concluded that the pathogenesis of this disorder was due to a tendency of the kidney to conserve Na+ and excrete K+ despite the virtual absence of mineralocorticoids. In the last several years the specific mechanism underlying this tendency has been elucidated. The disorder has been localized to a specific mutation in the epithelial Na+ channel located in the collecting duct of the kidney. This mutation results in constitutive overactivity of the channel, resulting in a clinical picture virtually identical to that of hyperaldosteronism. The sequence of events that started with the original report of this disorder and continued to the present day understanding of the precise molecular defect is illustrative of how keen clinical deductive reasoning and techniques of molecular biology can complement each other in enhancing our understanding of a clinical disorder.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Liddle GW
        • Bledsoe T
        • Coppage Jr, WS
        A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion.
        Trans Assoc Am Physicians. 1963; 76: 199-213
        • Botero-Velez M
        • Curtis JJ
        • Warnock DG
        Brief report: Liddle’s syndrome revisited. A disorder of sodium reabsorption in the distal tubule.
        NEJM. 1994; 330: 178-181
        • Shimkets RA
        • Warnock DG
        • Bositis CM
        • et al.
        Liddle’s syndrome.
        Cell. 1994; 79: 407-414
        • Hansson JH
        • Nelson-Williams C
        • Suzuki H
        • et al.
        Hypertension caused by a truncated epithelial sodium channel γ subunit.
        Nature Genetics. 1995; 11: 76-82
        • Tamura H
        • Schild L
        • Enomoto N
        • et al.
        Liddle disease caused by a missense mutation of β subunit of the epithelial sodium channel gene.
        J Clin Invest. 1996; 97: 1780-1784
        • Young WF
        • Hogan MJ
        • Klee GG
        • et al.
        Primary aldosteronism.
        Mayo Clin Proc. 1990; 65: 96-110
        • Rich GM
        • Ulick S
        • Cook S
        • et al.
        Glucocorticoid-remediable aldosteronism in a large kindred.
        Ann Intern Med. 1992; 116: 813-820
        • Kassirer JP
        • London AM
        • Goldman DM
        • Schwartz WB
        On the pathogenesis of metabolic alkalosis in hyperaldosteronism.
        Am J Med. 1970; 49: 306-315
        • Nakada T
        • Koike H
        • Akiya T
        • et al.
        Liddle’s syndrome, an uncommon form of hyporeninemic hypoaldosteronism.
        J Urology. 1987; 137: 636-640
        • Gonzalez-Campoy J
        • Romero J
        • Knox FG
        Escape from the sodium-retaining effects of mineralcorticoids.
        Kidney Int. 1989; 35: 767-777
        • Yokota N
        • Bruneau BG
        • de Bold ML
        • de Bold AJ
        Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon.
        J Clin Invest. 1994; 94: 1938-1946
        • Canessa CM
        • Horisberger J
        • Rossier BC
        Epithelial sodium channel related to proteins involved in neurodegeneration.
        Nature. 1993; 361: 467-470
        • Lingueglia E
        • Voilley N
        • Waldmann R
        • et al.
        Expression cloning of an epithelial amiloride-sensitive Na+ channel.
        FEBS Lett. 1993; 318: 95-99
        • Canessa CM
        • Schild L
        • Buell G
        • et al.
        Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.
        Nature. 1994; 367: 463-467
        • Ismailov I
        • Awayda MS
        • Berdiev BK
        • et al.
        Triple-barrel organization of ENaC, a cloned epithelial Na+ channel.
        J Biolog Chem. 1996; 271: 807-816
        • Benos DJ
        • Fuller CM
        • Shlyonsky VG
        • et al.
        Amiloride-sensitive Na+ channels.
        News Physiol Sci. 1997; 12: 55-62
        • Schild L
        • Canessa CM
        • Shimkets RA
        • et al.
        A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system.
        Proc Natl Acad Sci USA. 1995; 92: 5699-5703
      1. Warnock DG, Bubien JK. Liddle syndrome: clinical and cellular abnormalities. Hosp Practice 1994;July:95–106.

        • Bubien JK
        • Ismailov II
        • Berdiev BK
        • et al.
        Liddle’s disease.
        Am J Physiol. 1996; 270: C208-C213
        • Ismailov II
        • Berdiev BK
        • Fuller CM
        • et al.
        Peptide block of constitutively activated Na+ channels in Liddle’s disease.
        Am J Physiol. 1996; 270: C214-C223
        • Hansson JH
        • Schild L
        • Lu Y
        • et al.
        A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.
        Proc Natl Acad Sci USA. 1995; 92: 11495-11499
        • Schild L
        • Lu Y
        • Gautschi I
        • et al.
        Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome.
        EMBO J. 1996; 15: 2381-2387
        • Bork P
        • Sudol M
        The WW domain.
        TIBS. 1994; 19: 531-533
        • Andre B
        • Springael J
        WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding yes-associated protein YAP65.
        Biochem Biophys Res Comm. 1994; 205: 1201-1205
        • Chen HI
        • Sudol M
        The WW domain of yes-associated protein binds a proline-rich ligand that differs from the consensus established for src homology 3-binding modules.
        Proc Natl Acad Sci USA. 1995; 92: 7819-7823
        • Kumar S
        • Tomooka Y
        • Noda M
        Identification of a set of genes with developmentally down-regulated expression in the mouse brain.
        Biochem Biophys Res Comm. 1992; 185: 1155-1161
        • Staub O
        • Dho S
        • Henry PC
        • et al.
        WW domains off Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle’s syndrome.
        EMBO J. 1996; 15: 2371-2380
        • Zhang JZ
        • Davletov BA
        • Sudhof TC
        • Anderson RGW
        Synaptotagmin I is a high affinity receptor for clathrin AP-2.
        Cell. 1994; 78: 751-760
        • Scheffner M
        • Huibregtse JM
        • Vierstra RC
        • Howley PM
        The HPV-16 E6 and E6-AP complex functions as a ubiquintin-protein ligase in the ubiquitination of p53.
        Cell. 1993; 75: 495-505
        • Huibregtse JM
        • Scheffner M
        • Beaudenon S
        • Howley PM
        A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
        Proc Natl Acad Sci USA. 1995; 92: 2563-2567
        • Ciechanover A
        The ubiquitin-proteasome proteolytic pathway.
        Cell. 1994; 79: 13-21
        • Snyder PM
        • Price MP
        • McDonald FJ
        • et al.
        Mechanism by which Liddle’s syndrome mutations increase activity of a human epithelial Na+ channel.
        Cell. 1995; 83: 969-978